EUVIMEDEUVIMED entdecken
Crossref

HSR26-217: Refining Surgical Eligibility in Cirrhotic Hepatocellular Carcinoma: A Propensity-Matched TriNetX Analysis

Aqsa Zoey Sorathia, Islam M Rajab, Anwar Zahran

Journal of the National Comprehensive Cancer Network · 31.03.2026 · 24 (3.5)

DOI: 10.6004/jnccn.2025.7218 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the National Comprehensive Cancer Network, erschienen am 31.03.2026. Verfasst von Aqsa Zoey Sorathia und 2 weiteren Autor:innen. Beteiligte Einrichtung: 1Resident Physician, Department of Internal Medicine, St. Joseph's University Medical Center, Paterson, NJ.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • 1Resident Physician, Department of Internal Medicine, St. Joseph's University Medical Center, Paterson, NJ.
  • 2Medical Graduate, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine.

Zitieren

APA

Sorathia, A. Z., Rajab, I. M., & Zahran, A. (2026). HSR26-217: Refining Surgical Eligibility in Cirrhotic Hepatocellular Carcinoma: A Propensity-Matched TriNetX Analysis. Journal of the National Comprehensive Cancer Network, 24(3.5). https://doi.org/10.6004/jnccn.2025.7218

Vancouver

Sorathia AZ, Rajab IM, Zahran A. HSR26-217: Refining Surgical Eligibility in Cirrhotic Hepatocellular Carcinoma: A Propensity-Matched TriNetX Analysis. Journal of the National Comprehensive Cancer Network. 2026;24(3.5). doi:10.6004/jnccn.2025.7218

BibTeX
@article{Sorathia2026,
  author = {Sorathia, Aqsa Zoey and Rajab, Islam M and Zahran, Anwar},
  title = {HSR26-217: Refining Surgical Eligibility in Cirrhotic Hepatocellular Carcinoma: A Propensity-Matched TriNetX Analysis},
  journal = {Journal of the National Comprehensive Cancer Network},
  year = {2026},
  volume = {24},
  number = {3.5},
  doi = {10.6004/jnccn.2025.7218}
}
Kostenlos starten →